Andere Sprachen Silk Road Medical, Inc

Aktien

A2PFG4

US82710M1009

SILK

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
20,28 ^USD	+7,30 %		+13,93 %	+65,28 %

30.04.	Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024
30.04.	Silk Road Medical, Inc. gibt Umsatzprognose für das Gesamtjahr 2024 ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Silk Road Medical: Q1 Earnings Snapshot	30.04.
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q1 Revenue $48.5M, vs. Street Est of $44.7M	30.04.
Silk Road Medical Reports First Quarter 2024 Financial Results	30.04.
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024	30.04.
Silk Road Medical, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	30.04.
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference	23.04.
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024	09.04.
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS	02.04.
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuro Protection System Plus	02.04.
North American Morning Briefing : Stock Futures -2-	08.03.
Silk Road Medical Inc. and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products	08.03.
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	05.03.
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	05.03.
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered Enroute®? Transcarotid Stent System	05.03.
Silk Road Medical: Q4 Earnings Snapshot	28.02.
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q4 Revenue $47.3M, vs. Street Est of $42M	28.02.
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	28.02.
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024	28.02.
Silk Road Medical, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	28.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Silk Road Medical, Inc

Aktien

A2PFG4

US82710M1009

SILK

Andere Sprachen

Filter